Cancer Testing Services
Cancer is one of the most complex diseases, shaped not only by genetic mutations but also by the immune system’s interaction with tumors and the molecular environment that supports metastasis. Traditional diagnostics often miss the earliest molecular changes that precede visible tumors or focus narrowly on single markers.
Persona Biomed’s Cancer Testing Services provide a new dimension of precision diagnostics, focusing on immunocarcinogenic and prometastatic biomarker assays. These tests detect how the immune system responds to tumor development and how cancerous cells influence their microenvironment to spread. By analyzing these molecular patterns, our assays support early detection, personalized treatment guidance, and long-term monitoring.
Why Cancer Testing Services Matter
Key Benefits
Immune-Driven Insight
Goes beyond genetics to measure immune system activity driving cancer initiation and spread.
Early Detection Potential
Identifies prometastatic changes before tumors fully develop or metastasize.
Personalized Care
Provides molecular evidence to guide targeted therapies and immunotherapy strategies.
Comprehensive Monitoring
Tracks disease progression, recurrence, or treatment effectiveness.
Available Cancer Assays
Available Cancer Tests:
Detects immune activity and molecular disruptions associated with lung cancer initiation and progression, complementing imaging diagnostics.
Evaluates immune signatures linked to aggressive lymphoma subtypes, providing insight for diagnosis and targeted therapy.
Provides molecular evidence of ocular melanoma by measuring immune and prometastatic activity unique to eye tissue.
Detects immune biomarker activity associated with melanoma risk and progression in skin tissue.
Identifies immune-driven and prometastatic markers of pancreatic cancer, providing critical insights for a disease often diagnosed late.
Focuses on molecular and immune alterations specific to cholangiocarcinoma (bile duct cancer), supporting earlier and more accurate detection.
Detects immune and molecular changes in the liver environment that drive cancer progression and metastasis.
Evaluates prometastatic molecular activity that signals colorectal cancer progression and risk of spread, supporting proactive interventions.
Provides insight into molecular and immune responses tied to kidney cancer, enabling early diagnosis and precision treatment planning.
Identifies immune-related biomarker changes linked to cervical cancer, enhancing screening and risk assessment beyond standard cytology.
Get Started
Register now for Persona Biomed Cancer Testing Services to uncover hidden molecular signals of cancer and guide precision-driven care.
